Liver Cirrhosis in Patients With Atrial Fibrillation: Would Oral Anticoagulation Have a Net Clinical Benefit for Stroke Prevention?

BACKGROUND: Patients with liver cirrhosis have been excluded from randomized clinical trials of oral anticoagulation therapy for stroke prevention in atrial fibrillation. We hypothesized that patients with liver cirrhosis would have a positive net clinical benefit for oral anticoagulation when used...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Am Heart Assoc
Main Authors: Kuo, Ling, Chao, Tze‐Fan, Liu, Chia‐Jen, Lin, Yenn‐Jiang, Chang, Shih‐Lin, Lo, Li‐Wei, Hu, Yu‐Feng, Tuan, Ta‐Chuan, Liao, Jo‐Nan, Chung, Fa‐Po, Chen, Tzeng‐Ji, Lip, Gregory Y. H., Chen, Shih‐Ann
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2017
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5669162/
https://ncbi.nlm.nih.gov/pubmed/28645935
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.116.005307
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki